Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient

Targeted Oncology

Volumn 2, Issue 3, 2007, Pages 193-195

  Medioni, Jacques ^a   Cojocarasu, Oana ^a   Banu, Eugeniu ^a   Cassar Queudeville, Alexia ^a   Halimi, Philippe ^a   Oudard, Stéphane ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Posterior reversible encephalopathy syndrome; Renal cancer; Sunitinib

Indexed keywords

EID: 34547159685     PISSN: 17762596     EISSN: 1776260X     Source Type: Journal    
DOI: 10.1007/s11523-007-0050-9     Document Type: Article

References (8)

1. Elahi A, Kelkar P, St Louis EK (2004) Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barre Syndrome. Neurocrit Care 1:465-468
2. Gokce M, Dogan E, Nacitarhan S et al (2006) Posterior reversible encephalopathy syndrome caused by hypertensive encephalopathy and acute uremia. Neurocrit Care 4:133-136
3. Motzer RJ, Hutson TE, Tomczak P et al (2006) Phase III randomized trial of sunitinib malate (SU11248) versus interferonalfa (IFN-α) as first-line systemic therapy for patients with metastatic renal cell carcinoma (mRCC). J Clin Oncol 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement): LBA3 24
4. Motzer RJ, Rini BI, Bukowski RM et al (2006) Sunitinib in patients with metastatic renal cell carcinoma. JAMA 295:2516-2524
5. Ozcan C, Wong SJ, Hari P (2006) Reversible posterior leukoen-cephalopathy syndrome and bevacizumab. N Engl J Med 354(9):980-982
6. Allen JA, Adlakha A, Bergethon PR (2006) Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol 63(10):1475-1478
7. Govindarajan R, Adusumilli A, Baxter DL et al (2006) Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. J Clin Oncol 24:e48
8. Pandey R, Patel A, Shah S et al (2006) A rare complication in a case of multiple myeloma on therapy with thalidomide and dexamethasone-reversible posterior lobe leukoencephalopathy. Leuk Lymphoma 47(7):1431-1434